Difference between revisions of "Team:Wageningen UR/Demonstrate"

 
(38 intermediate revisions by 3 users not shown)
Line 10: Line 10:
  
 
             <div class="Main-Border">
 
             <div class="Main-Border">
 +
                <div id="SideMenu-Wrapper">
 +
                    <div id="nav-anchor"></div>
 +
                    <sidenav id="SideMenu">
  
 +
                        <div class="menu-head">
 +
                            <h4>Demonstrate</h4>
 +
                        </div>
 +
                        <ul class="sidebar-nav">
 +
                            <li class="menu-item">
 +
                                <a href="#celldrying">Cell Drying</a>
 +
                            </li>
 +
                            <li>
 +
                                <a href="#cellfluorescence">Cell Viability</a>
 +
                            </li>
 +
                            <li>
 +
                                <a href="#improvement">Improving the Fluorescent Signal</a>
 +
                            </li>
 +
                            <li>
 +
                                <a href="#combination">Direct Visualizing Antigen Binding</a>
 +
                            </li>
 +
                        </ul>
 +
 +
                    </sidenav>
 +
                </div>
 
                 <div class="Main-Center-Content-Column Overview">
 
                 <div class="Main-Center-Content-Column Overview">
 
                     <div id="breadcrumb-wrapper">
 
                     <div id="breadcrumb-wrapper">
 
                         <ul class="breadcrumb">
 
                         <ul class="breadcrumb">
 
                             <li><a href="https://2017.igem.org/Team:Wageningen_UR">Home</a></li>
 
                             <li><a href="https://2017.igem.org/Team:Wageningen_UR">Home</a></li>
                             <li><a href="https://2017.igem.org/Team:Wageningen_UR/Application">Application</a></li>
+
                             <li><a href="https://2017.igem.org/Team:Wageningen_UR/Applied_Design">Application</a></li>
 
                             <li>Demonstrate</li>
 
                             <li>Demonstrate</li>
 
                         </ul>
 
                         </ul>
Line 23: Line 46:
 
                     <section class="MI intro">
 
                     <section class="MI intro">
 
                         <div class="Title">
 
                         <div class="Title">
                             <h1>Demo</h1> </div>
+
                             <h1>Demonstrate</h1> </div>
  
 
                         <div class="Textbox Results-Desc">
 
                         <div class="Textbox Results-Desc">
Line 32: Line 55:
 
                                     <div class="figure-center-imagebox.Banner-box">
 
                                     <div class="figure-center-imagebox.Banner-box">
 
                                         <img class="figure-center-img bnl_banner" src="https://static.igem.org/mediawiki/2017/4/40/T--Wageningen_UR--DemoDemo.png" />
 
                                         <img class="figure-center-img bnl_banner" src="https://static.igem.org/mediawiki/2017/4/40/T--Wageningen_UR--DemoDemo.png" />
                                       
+
 
 
                                     </div>
 
                                     </div>
 
                                 </div>
 
                                 </div>
 
                             </div>
 
                             </div>
<p>
+
                            <p>
Here we show how we brought individual lab projects together and how we implement them in our device! We performed experiments in which we show that our cells are still viable after drying (which means that they can safely be shipped and still work properly), and that we can measure fluorescence in blood serum! Furthermore we combine the Signal Transduction and Specific Visualization modules to directly measure antigens by coupling the affinity molecule, Cpx signal transduction and Bimolecular Fluorescence Complementation (BiFC) specific visualization.  
+
                                Here we show how we brought individual lab projects together and how we implemented them in our device! We performed experiments in which we show that our cells are still viable after drying (which means that they can be safely shipped and still work properly), and that we can measure fluorescence in blood serum.
 
                             </p>
 
                             </p>
 
+
                             <p>
                              
+
                                We combined the <a href="https://2017.igem.org/Team:Wageningen_UR/Results/SpecificVisualization"> "Specific Visualization"</a> and <a href="https://2017.igem.org/Team:Wageningen_UR/Results/Fluorescent"> "Fluorescent Protein"</a> modules, by which we aimed to optimize the fluorescent signaling system of Mantis. Furthermore we combined the <a href="https://2017.igem.org/Team:Wageningen_UR/Results/Cpx"> "Signal Transduction"</a> and <a href="https://2017.igem.org/Team:Wageningen_UR/Results/SpecificVisualization"> "Specific Visualization"</a> modules to directly measure antigens by coupling the affinity molecule, Cpx signal transduction and Bimolecular Fluorescence Complementation (BiFC) specific visualization.
+
                            </p></section>
+
  
 
                         </div>
 
                         </div>
                     </section>
+
                      
  
                     <section class="cell drying">
+
                     <section id="celldrying">
 +
<br>
 
                          
 
                          
                         <div class="Title">
+
                         <section class="cell drying">
                            <h2>Cell Drying</h2> </div>
+
<br>
<p>
+
In order to ship our bacterial system to the local health care centre (and to be used in the field later) we need to dry the cells in order to be able to ship them safely and keep them viable. We air-dry cells in a clay-matrix (Kaolin) [1] in which the cells can safely be shipped. Here we show that our cells stay viable after drying and adding clay! </p><p>
+
+
<div class="figure-fullwidth">
+
                            <div class="figure-center-imagebox.Banner-box">
+
                                <img class="figure-center-img bnl_banner" src="https://static.igem.org/mediawiki/2017/d/d2/T--Wageningen_UR--Cpx_Systems.png" />
+
                            </div>
+
                            <div class="figure-center-caption">
+
                                <b>Figure 1:</b> <mark> placeholder </mark>
+
                            </div>
+
                        </div>
+
+
</section>
+
+
<section class="Cell viability and fluorescence in blood serum">
+
                       
+
                        <div class="Title">
+
                            <h2>Cell Viability and Fluorescence in Blood Serum</h2> </div>
+
<p>
+
Next up, we need to know if our cells can survive and function properly when we add a blood sample to measure antigens. We took several steps to investigate this. First, we analyzed if <i>Escherichia coli </i> could grow in (dilutions of) horse blood serum. To do this, we grew cultures with several ratios of Lysogeny Broth (LB) to horse blood serum overnight. The results can be found in Figure 2.
+
</p>
+
+
<div class="figure-fullwidth">
+
                            <div class="figure-center-imagebox.Banner-box">
+
                                <img class="figure-center-img bnl_banner" src="https://static.igem.org/mediawiki/2017/d/d2/T--Wageningen_UR--Cpx_Systems.png" />
+
                            </div>
+
                            <div class="figure-center-caption">
+
                                <b>Figure 2:</b> <mark> placeholder </mark> <i>E. coli</i> is grown in LB with added horse blood serum in different ratios. Cells were grown overnight in 2 mL cultures and the optical density at 600 nm was measured after 18 hours.
+
  
                             </div>
+
                             <div class="Title">
                        </div>
+
                                <h2>Cell Drying</h2> </div>
+
                             <p>
<p>
+
                                 In order to ship our bacterial system to the local healthcare center (and to be used in the field later) we need to dry the cells in order to be able to ship them safely and keep them viable.
We show that <i>E. coli</i> is able to grow in horse blood serum concentrations up to 75%! This means that our cells would be viable when a small amount of growth medium is added before measuring, which prevents a big dilution of the antigen and, subsequently, a lower fluorescent signal.
+
</p><p>
+
In addition, we tested if fluorescence can be measured in blood. We grew <i>E. coli</i> K12 containing eYFP <mark>(BBa_K2387003) in the pSB1C3 plasmid <mark>BBa_K2387003</mark> overnight in LB.  These cells were centrifuged and resuspended in 1 mL of LB with added horse blood serum (the same dilutions were used as in the viability test above) and YFP was matured at 30 &#176;C. Fluorescence was measured after six hours.
+
</p>
+
<div class="figure-fullwidth">
+
                            <div class="figure-center-imagebox.Banner-box">
+
                                <img class="figure-center-img bnl_banner" src="https://static.igem.org/mediawiki/2017/d/d2/T--Wageningen_UR--Cpx_Systems.png" />
+
                            </div>
+
                             <div class="figure-center-caption">
+
                                 <b>Figure 3:</b> eYFP fluorescence measured in E. coli resuspended in several LB to horse blood serum ratios. eYFP was excited at 512 nm and measured at 528 nm. Measurements taken after 6 hours.
+
  
 +
                            </p>
 +
                            <p>
 +
                                The first experiment consisted of making an overnight culture of <i>Escherichia coli</i> DH5α. Different amounts of kaolin clay (Merck) [1] were added to 2 mL of this culture (<i>in duplo</i>) and left to dry overnight in a laminar flow cabinet on a Petri dish. The next day the cell/clay mixture was scraped off the Petri dish and resuspended in 1 ml of SOC medium. Of this suspension, 100 µl was put on LB agar plates and left to incubate overnight at 37ºC. The next day, the number of colonies were counted and compared to the control, to which no kaolin clay was added. This experiment was repeated under identical conditions, but the drying period was extended to two weeks.
 +
                            </p>
 +
                            <p>
 +
                                In Figure 1, the number of colonies normalized with regards to the control sample is given on the Y-axis. A clear difference in the survival rate of the bacteria that were revived after 1 day when compared to the rest can be observed. The sample to which 0.1 grams of clay was added to the cell culture has a significantly higher survival rate compared to the control sample. This result gives an indication that drying cells in a kaolin clay matrix is an improvement over drying cells without a clay matrix.
 +
                            </p>
 +
                            <p>
 +
                                However, when samples were kept dry for 2 weeks at room temperature there seems to be no significant difference in the survival rate compared to the control sample.
 +
                            </p>
  
 +
                            <div class="figure-fullwidth">
 +
                                <div class="figure-center-imagebox.Banner-box">
 +
                                    <img class="figure-center-img bnl_banner" src="https://static.igem.org/mediawiki/2017/9/95/T--Wageningen_UR--CellDrying.jpg" />
 +
                                </div>
 +
                                <div class="figure-center-caption">
 +
                                    <b>Figure 1:</b> Relative survival rates of <i>E. coli</i> dried in a clay matrix as opposed drying without cell matrix.
 +
                                </div>
 
                             </div>
 
                             </div>
                        </div>
 
<p>
 
Here we show that fluorescence can be measured in all blood serum dilutions, whereas the negative controls containing no eYFP show negligible fluorescence!
 
</p>
 
</section>
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
<!--Accordion of IM-->
 
  
+
                         </section>
                         <div class="panel-group" id="accordion" role="tablist" aria-multiselectable="true">
+
                    </section>
                            <div class="panel panel-default">
+
                                <div class="panel-heading" role="tab" id="headingOne">
+
                                    <a data-toggle="collapse" data-parent="#accordion" href="#IM" aria-expanded="true" aria-controls="IM">
+
                                        <h4 class="panel-title">
+
<div class="col-xs-11">
+
<b>Phase 1</b>: Initial system modeling
+
</div><div class="col-xs-1"><i class="fa fa-arrow-down" aria-hidden="true"></i></div></a></h4>
+
                                </div>
+
  
                                <div id="IM" class="panel-collapse collapse" role="tabpanel" aria-labelledby="headingOne">
+
<section class="Cell viability and fluorescence in blood serum">
                                    <div class="panel-body bg-primary">
+
<br>                   
                                        <!--Text for IM-->
+
<section id="cellfluorescence">
 +
                      <br>
 +
                       
 +
                            <div class="Title">
 +
                                <h2>Cell Viability and Fluorescence in Blood Serum</h2> </div>
 +
                            <p>
 +
                                Next up, we need to know if our cells can survive and function properly when we add a blood sample to measure antigens. We took several steps to investigate this. First, we analyzed if <i>E. coli </i> could grow in (dilutions of) horse blood serum. To do this, we grew cultures with several ratios of Lysogeny Broth (LB) to horse blood serum overnight. The results can be found in Figure 2.
 +
                            </p>
  
                                        <div class="col-xs-4 banner-column" style="float: right;">
+
                            <div class="figure-center">
                                            <div class="figure-fullwidth">
+
                                <div class="figure-center-imagebox.Banner-box">
                                                <div class="figure-center-imagebox.Banner-box">
+
                                    <img class="figure-center-img bnl_banner" src="https://static.igem.org/mediawiki/2017/1/15/T--Wageningen_UR--Ecoli_Survival.png" />
                                                    <img class="figure-center-img bnl_banner" src="https://static.igem.org/mediawiki/2017/3/32/T--Wageningen_UR--CpxR_dimerization.png" />
+
                                </div>
                                                    <div class="figure-center-caption">
+
                                <div class="figure-center-caption">
                                                        <b>Figure A:</b> eYFPn and eYFPc are fused to CpxR. This way BiFC is used to visualize the CpxR dimerization step.
+
                                    <b>Figure 2:</b> <i>E. coli</i> is grown in LB with added horse blood serum in different ratios. Cells were grown overnight in 2 mL cultures and the optical density at 600 nm was measured after 18 hours. Culture growth relative to the 0% blood serum sample (%) is plotted.
  
                                                    </div>
+
                                </div>
                                                </div>
+
                            </div>
                                            </div>
+
                                        </div>
+
  
                                        <p>
+
                            <p>
                                            Firstly, we targeted to find out which protein-protein interactions in the Cpx pathway were most suited to connect to BiFC. Three candidate systems were analyzed, which were based on either CpxA-CpxR phosphotransfer or CpxR-CpxR dimerization (figure 1). While the constructs for the wet lab were created, initial <i>in silico</i> tests were ran. We defined protein expression and signal activation through addition of stress as the most important to test; these would later also be tested in the wet lab.
+
                                We show that <i>E. coli</i> is able to grow in horse blood serum concentrations up to 75%. This means that our cells would be viable when a small amount of growth medium is added before measuring, which prevents a high dilution of the antigen and, subsequently, a lower fluorescent signal.
                                        </p>
+
                            </p>
                                        <p>
+
                            <p>
                                            We quickly found out that in theory, CpxR-CpxR dimerization (figure A) was the most promising protein interaction to experiment with in the lab.
+
                                In addition, we tested if fluorescence can be measured in blood. We grew <i>E. coli</i> K12 containing <a href="http://parts.igem.org/Part:BBa_K2387003"> eYFP under control of the araC/pBAD promoter</a> overnight in LB. These cells were centrifuged and resuspended in 1 mL of LB with added horse blood serum (the same dilutions were used as in the viability test above) and YFP was matured at 30 &#176;C. Fluorescence was measured after six hours.
                                        </p>
+
                            </p>
 +
                            <div class="figure-center">
 +
                                <div class="figure-center-imagebox.Banner-box">
 +
                                    <img class="figure-center-img bnl_banner" src="https://static.igem.org/mediawiki/2017/3/30/T--Wageningen_UR--Ecoli_Fluorescence.png" />
 +
                                </div>
 +
                                <div class="figure-center-caption">
 +
                                    <b>Figure 3:</b> eYFP fluorescence measured in <i>E. coli</i> resuspended in several LB to horse blood serum ratios. eYFP was excited at 512 nm and measured at 528 nm. Measurements taken after 6 hours.
  
                                        <p>
 
                                            Results of all three setups can be seen at the (link) modeling page. Although the CpxA-CpxR setup is dependent on the right CpxA and antigen levels in the sample, it seems that the CpxR-CpxR setup is not dependent on any protein concentration. It even shows that the maximum reached YFP concentration is limited by CpxR, which can be increased in the lab. <b>The strongest signal will be obtained when CpxR expression and Cpx activation are maximized </b>(figure B).
 
                                        </p>
 
                                        <p>
 
                                            We went into the lab to test these propositions!
 
                                        </p>
 
 
                                        <div class="figure-center-imagebox.Banner-box">
 
                                            <img class="figure-center-img bnl_banner" src="https://static.igem.org/mediawiki/2017/b/b0/T--Wageningen_UR--InitModelCpxRdimerization.png" />
 
                                            <div class="figure-center-caption">
 
                                                <b>Figure B:</b> Fluorescent signal intensity (orange) and signaling speed (green) are plotted against [CpxR].
 
 
                                            </div>
 
                                        </div>
 
 
                                    </div>
 
 
                                 </div>
 
                                 </div>
 
                             </div>
 
                             </div>
                         </div>
+
                            <p>
 +
                                Here we show that fluorescence can be measured in all blood serum dilutions, whereas the negative controls containing no eYFP show negligible fluorescence.
 +
                            </p>
 +
                         </section>
 
                     </section>
 
                     </section>
  
                     <section class="Improving the Fluorescent Signal">
+
                     <section id="improvement">
                       
+
                      <br>
                        <div class="Title">
+
                        <section class="Improving the Fluorescent Signal">
                            <h2>Improving the Fluorescent Signal</h2> </div>
+
<br>
<div class="col-lg-6 banner-column" style="float: right;">
+
                            <div class="Title">
 +
                                <h2>Improving the Fluorescent Signal</h2> </div>
 +
                            <div class="col-lg-5 banner-column" style="float: right;">
 
                                 <div class="figure-fullwidth">
 
                                 <div class="figure-fullwidth">
 
                                     <div class="figure-center-imagebox.Banner-box">
 
                                     <div class="figure-center-imagebox.Banner-box">
 
                                         <img class="figure-center-img bnl_banner" src="https://static.igem.org/mediawiki/2017/3/32/T--Wageningen_UR--CpxR_dimerization.png" />
 
                                         <img class="figure-center-img bnl_banner" src="https://static.igem.org/mediawiki/2017/3/32/T--Wageningen_UR--CpxR_dimerization.png" />
 
                                         <div class="figure-center-caption">
 
                                         <div class="figure-center-caption">
                                             <b>Figure 4:</b> eYFPn and eYFPc are fused (seperately) to CpxR. This way BiFC is used to visualize the CpxR dimerization step.
+
                                             <b>Figure 4:</b> eYFPn and eYFPc are fused (seperately) to CpxR. This way BiFC is used to visualize the CpxR dimerization step. [2].
                                            [2].
+
 
                                         </div>
 
                                         </div>
 
                                     </div>
 
                                     </div>
 
                                 </div>
 
                                 </div>
 
                             </div>
 
                             </div>
 
<p>
 
We visualize antigen binding using the Cpx pathway by fusing split fluorophores to interacting proteins. Through a combination of wet- and dry-lab work, we found that a system based on CpxR dimerization <mark>(link MI page)</mark>yields the best results using bimolecular fluorescence complementation (BiFC) (Figure 4). We used eYFP, split after amino acid 154, as the reporter. This is a commonly used fluorescent reporter in BiFC [2].
 
  
</p><p>
+
                            <p>
We aim to improve this reporter, both in signal intensity and response time. During our <mark>“Fluorescent Protein”</mark> project we tested a number of fluorescent proteins, of which mVenus showed the shortest maturation time. Furthermore mVenus is designed to have a fast and efficient maturation time [3], exactly what we need!
+
                                We visualize antigen binding using the Cpx pathway by fusing split fluorophores to interacting proteins. Through a combination of <a href="https://2017.igem.org/Team:Wageningen_UR/Model/IntegrationCpx#Initial_Modeling"> wet- and dry-lab work</a>, we found that a system based on CpxR dimerization yields the best results using Bimolecular Fluorescence Complementation (BiFC) (Figure 4). We used eYFP, split after amino acid 154, as the reporter. This is a commonly used fluorescent reporter in BiFC [2].
<p><p>
+
Also, our Cpx pathway model <mark>integration (LINK)</mark> showed that several interactions of the Cpx pathway visualization can be improved, of which using a fluorescent protein with a decreased maturation time was the most feasible to attempt in a laboratory setting.
+
</p><p>
+
We fused mVenus-termini to the C-terminus of <mark>CpxR(link)</mark> in the same fashion as we did with eYFP <mark>Link results Bart</mark> and transformed this to <i>E. coli</i> K12. Experiments with mVenus were performed using the same protocol with optimal induction and activation parameters used during experiments with eYFP, and can be found <mark>here (LINK)</mark>.
+
</p>
+
<div class="figure-fullwidth">
+
                            <div class="figure-center-imagebox.Banner-box">
+
                                <img class="figure-center-img bnl_banner" src="https://static.igem.org/mediawiki/2017/d/d2/T--Wageningen_UR--Cpx_Systems.png" />
+
                            </div>
+
                            <div class="figure-center-caption">
+
                                <b>Figure 5:</b> <mark> placeholder </mark> CpxR dimerization visualized using mVenus, with a L-arabinose concentration of 0.2% w/v and different activator (KCl) concentrations over time.
+
  
                             </div>
+
                             </p>
                        </div>
+
                            <p>
+
                                We aim to improve this reporter, both in signal intensity and response time. During our <a href="https://2017.igem.org/Team:Wageningen_UR/Results/Fluorescent#Comparing"> "Fluorescent Protein"</a> project we tested a number of fluorescent proteins, of which mVenus showed the shortest maturation time. Furthermore mVenus is designed to have a fast and efficient maturation time [3], exactly what we need!
+
                            </p>
<p>
+
                            <p>
The results show that usage of mVenus over eYFP as a reporter protein increases the produced fluorescent signal some ten times! Unfortunately, the background signal also increases a lot, which means we lose specificity of our response. We hypothesize that the maturation rate of mVenus is too high, which means that many non-specific interactions become irreversible, leading to high fluorescent signals  even when no activator is present. This means that mVenus is not a suitable candidate to visualize antigen binding within our diagnostic.
+
                                Also, our <a href="https://2017.igem.org/Team:Wageningen_UR/Model/Cpx_Kinetics#dataFit"> Cpx pathway model </a> showed that several interactions of the Cpx pathway visualization can be improved, of which using a fluorescent protein with a decreased maturation time was the most feasible to attempt in a laboratory setting.
</p><p>
+
                            </p>
During this project, more reporter proteins were tested. Unfortunately we didn’t have time to test these in the CpxR dimerization setup. At this moment, we recommend testing sfGFP <mark>(link)</mark> as a reporter for antigen binding. We found that sfGFP is thermostable, i.e. it matures efficiently at high temperatures, while still being one of the fastest and brightest reporters we tested. You can check these experiments <mark>here(LINK JOSE)</mark>.
+
                            <p>
</p>
+
                                We fused <a href="http://parts.igem.org/Part:BBa_K2387029"> mVenus-termini to the C-terminus of CpxR</a> in the same fashion as we did with eYFP and transformed this to <i>E. coli</i> K12. <a href="https://2017.igem.org/Team:Wageningen_UR/Results/SpecificVisualization#optimalactivation">Experiments with mVenus </a> were performed using the same protocol with optimal induction and activation parameters used during experiments with eYFP, and can be found <a href="https://static.igem.org/mediawiki/2017/d/d4/Cpx_Dimerization.pdf"> here</a>.
+
                            </p>
</section>
+
                            <div class="figure-fullwidth">
+
                                <div class="figure-center-imagebox.Banner-box">
+
                                    <img class="figure-center-img bnl_banner" src="https://static.igem.org/mediawiki/2017/b/b0/T--Wageningen_UR--CpxR_dimerization_eYFP_Venus.png" />
+
+
+
+
<!--Accordion of ID-->
+
                    <section class="ID">
+
                        <div class="panel-group" id="accordion" role="tablist" aria-multiselectable="true">
+
                            <div class="panel panel-default">
+
                                <div class="panel-heading" role="tab" id="headingOne">
+
                                    <a data-toggle="collapse" data-parent="#accordion" href="#ID" aria-expanded="true" aria-controls="ID">
+
                                        <h4 class="panel-title">
+
<div class="col-xs-11">
+
<b>Phase 2</b>: Testing model propositions in the lab 
+
</div>
+
<div class="col-xs-1"><i class="fa fa-arrow-down" aria-hidden="true"></i></div></a></h4>
+
 
                                 </div>
 
                                 </div>
 +
                                <div class="figure-center-caption">
 +
                                    <b>Figure 5:</b> CpxR dimerization visualized using eYFP (left) and mVenus (right), with a L-arabinose concentration of 0.2% (w/v) and different activator (KCl) concentrations over time.
  
                                 <div id="ID" class="panel-collapse collapse" role="tabpanel" aria-labelledby="headingOne">
+
                                 </div>
                                    <div class="panel-body bg-primary">
+
                            </div>
                                        <!--Text for ID-->
+
  
                                        <p>
+
                            <p>
                                            To test these hypotheses, we created constructs in which we coupled split eYFP halves to CpxA and CpxR respectively and placed them under control of the inducible araC/pBAD promoter. We transformed E. coli K12 with these constructs. The Cpx system was activated with the known activator KCl in different concentrations to mimic different antigen levels at t = 20 min.
+
                                The results show that usage of mVenus over eYFP as a reporter protein increases the produced fluorescent signal more then five times. Unfortunately, the background signal also increases a lot, which means we lose specificity of our response. We hypothesize that the maturation rate of mVenus is too high, which means that many non-specific interactions become irreversible, leading to high fluorescent signals even when no activator is present. This means that mVenus is not a suitable candidate to visualize antigen binding within our diagnostic.
                                            <mark>Here (link)</mark> an extensive overview of the performed experiments can be found!</p>
+
                            </p>
                                        </p>
+
                            <p>
                                        <p>
+
                                During this project, more reporter proteins were tested. Unfortunately we didn’t have time to test these in the CpxR dimerization setup. At this moment, we recommend testing <a href="http://parts.igem.org/Part:BBa_K2387047"> sfGFP</a> as a reporter for antigen binding. We found that sfGFP is thermostable, i.e. it matures efficiently at high temperatures, while still being one of the fastest and brightest reporters we tested. You can see the results of these experiments <a href="https://2017.igem.org/Team:Wageningen_UR/Results/Fluorescent#Comparing"> here</a>.
                                            We quickly found out that the systems based on CpxA-CpxR interaction did not generate a clear fluorescent signal, which matches the prediction of the model! Furthermore, we show that visualizing CpxR dimerization with BiFC is indeed a viable option. Because we put the CpxR-eYFP-termini construct under control of the inducible araC/pBAD promoter we were able to test hypothesis 1: <b>The strongest signal will be obtained when CpxR expression is maximized</b>. We found out that this is indeed true. You can check this result
+
                            </p>
                                            <mark> here (Link Bart results)</mark>.
+
                                        </p>
+
                                        <p>
+
                                            We then set to test hypothesis 2: <b> The strongest signal will be obtained when Cpx activation is maximized</b>. In figure 3 we show that this is also true! We mimic antigen binding by adding a known activator of the Cpx pathway, and by increasing its concentration the fluorescence intensity also rises!
+
                                        </p>
+
                                        </p>
+
                                        We take this data back to the lab to further improve our computer model!
+
                                        </p>
+
  
                                        <div class="figure-center-imagebox.Banner-box">
+
                        </section>
                                            <img class="figure-center-img bnl_banner" src="https://static.igem.org/mediawiki/2017/0/09/T--Wageningen_UR--CpxR-KClconcentrations.png" />
+
                    </section>
                                            <div class="figure-center-caption">
+
                                                <b>Figure C:</b> CpxR dimerization visualized with L-arabinose concentration = 0.2% and different activator concentrations over time.
+
  
                                            </div>
+
                    <section id="combination">
                                         </div>
+
                        <br>
 +
                        <section class="Directly visualizing antigen binding">
 +
<br>
 +
                            <div class="Title">
 +
                                <h2>Directly Visualizing Antigen Binding</h2> </div>
 +
 
 +
                            <div class="col-lg-5 banner-column" style="float: right;">
 +
 
 +
                                <div class="figure-center">
 +
                                    <div class="figure-center-imagebox">
 +
                                         <img class="figure-center-img" src="https://static.igem.org/mediawiki/2017/3/3a/T--Wageningen_UR--Ab_BiFC.png" />
 +
 
 +
                                    </div>
 +
                                    <div class="figure-center-caption">
 +
                                        <b>Figure 6:</b> Schematic of direct visualization of antigens. When an antigen is present, it is bound by the affibody-CpxP fusion and titrates away from transmembrane protein CpxA. CpxA is subsequently activated and autophosphorylates. This phosphoryl group is transferred to response regulator CpxR. Phosphorylated CpxR can subsequently homodimerize, this protein-protein interaction is visualized by fusing split eYFP-termini to the CpxR-C-terminus. Once CpxR homodimerizes, eYFP reassembles and its fluorescence is restored.
  
 
                                     </div>
 
                                     </div>
 
                                 </div>
 
                                 </div>
 
                             </div>
 
                             </div>
                        </div>
 
                    </section>
 
  
                 
+
                            <p>
                    <section class="Directly visualizing antigen binding">
+
                                Here we test the direct coupling of the projects <a href="https://2017.igem.org/Team:Wageningen_UR/Results/Cpx">“Signal Transduction” </a> and <a href="https://2017.igem.org/Team:Wageningen_UR/Results/SpecificVisualization">“Specific Visualization”</a>, where we express the whole detection system in one cell, from affinity body to BiFC (Figure 6). While we induced Cpx activation by addition of KCl in the Specific Visualization project (to mimic antigen presence), here we actually measure antigen binding.
                      <div class="Title">
+
                             </p>
                             <h2>Directly Visualizing Antigen Binding</h2> </div>
+
                            <p>
<p>
+
                                A functional affinity body against rabbit IgG [4] was fused to the N-terminus of Cpx inhibitor CpxP (which resides in the periplasm [5]). To determine if IgG can induce the Cpx pathway <a href="http://parts.igem.org/Part:BBa_K2387025">(BBa_K2387025)</a>, the outer membrane of <i>E. coli</i> has to be removed, as IgG cannot penetrate the outer membrane [6]. This is done through a method called spheroplasting. To prevent CpxP from freely titrating away from the membrane it is tethered to the inner membrane by fusion to a transmembrane Maltose-Binding Protein (MBP) mutant [7]. This fusion was placed under control of the IPTG inducible tac promoter <a href="http://parts.igem.org/Part:BBa_K864400">(BBa_K864400)</a>.
Here we test a direct coupling of the projects “Signal Transduction” and “Specific Visualization”, where we express the whole detection system in one cell, from affibody to BiFC.  
+
                            </p>
</p>
+
                            <p>
<div class="figure-fullwidth">
+
                                To rapidly translate the generated signal upon IgG binding, Cpx pathway activation is visualized using BiFC. Split eYFP is used as a reporter, and its N- and C-termini are fused to the C-terminus of response regulator CpxR <a href="http://parts.igem.org/Part:BBa_K2387032">(BBa_K2387032)</a>. These fusions were placed under control of the L-arabinose inducible pBad/araC promoter<a href="http://parts.igem.org/Part:BBa_I0500">(BBa_BI0500)  </a>. Upon dimerization of CpxR, as a result of the Cpx system activation, the two eYPF halves are combined, leading to yellow fluorescence.
                            <div class="figure-center-imagebox.Banner-box">
+
                            </p>
                                <img class="figure-center-img bnl_banner" src="https://static.igem.org/mediawiki/2017/d/d2/T--Wageningen_UR--Cpx_Systems.png" />
+
                            <p>
                            </div>
+
                                To combine these systems (Figure 6), <i>E. coli</i> K12&#916;CpxP was cotransformed with these systems. <a href="http://parts.igem.org/Part:BBa_K2387025">BBa_K2387025</a> was placed in medium copy number plasmid <a href="http://parts.igem.org/Part:pSB3T5"> pSB3T5</a> to enable this.
                            <div class="figure-center-caption">
+
                            </p>
                                <b>Figure 1:</b> <mark> placeholder </mark>
+
                            <p>
 +
                                Cells were grown following the <a href="https://static.igem.org/mediawiki/2017/d/d4/Cpx_Dimerization.pdf">spheroplasting protocol</a>. Cells were induced with 0.2% L-arabinose and 0.05 - 0.2 mM IPTG before growing them at 37 &#176;C; the Cpx system was activated by addition of 0.1 mg IgG at timepoint 0 min. As a control, non-spheroplasted cells were used; we assume IgG cannot penetrate the outer membrane [6]. Fluorescence was measured at 27 &#176;C. spheroplasts are expected to remain for five generation before fully regenerating their outer membrane [8].
 +
                            </p>
 +
 
 +
                            <div class="figure-fullwidth">
 +
                                <div class="figure-center-imagebox.Banner-box">
 +
                                    <img class="figure-center-img bnl_banner" src="https://static.igem.org/mediawiki/2017/f/f6/T--Wageningen_UR--AntigenBindingUpdated.png" />
 +
                                </div>
 +
                                <div class="figure-center-caption">
 +
                                    <b>Figure 7:</b> Fluorescence/OD<sub>600</sub> values measured over time. Native <i>E. coli</i> K12&#916;CpxP (JW5558(-)) were used as negative controls for both spheroplasted (Sp.) and non-spheroplasted (non-Sp.) cultures.
 +
                                    <i>E. coli</i> K12&#916;CpxP containing CpxP-Affibody-MBP fusion <a href="http://parts.igem.org/Part:BBa_K2387025">(BBa_K2387025)</a> and CpxR-eYFPn-CpxR-eYFPc fusions <a href="http://parts.igem.org/Part:BBa_K2387032">(BBa_K2387032)</a>(CpxR-Ab) were induced with 0.2% L-arabinose (L-ara) and 0.05 - 0.2 mM IPTG. 0.1 mg IgG was added at time-point 0. Spheroplasted and non-spheroplasted cells were induced and activated equally.
 +
                                </div>
 
                             </div>
 
                             </div>
                        </div>
+
                            <p>
+
                                In Figure 7 it is visible that a fluorescent signal is generated after addition of IgG. In both the spheroplasted and non-spheroplasted cells an increase in fluorescence is visible within the first 100 minutes, after which the signal decreases and stabilizes. For both the spheroplasted and non-spheroplasted cells the measured fluorescent signals are much higher than in their negative controls.
</section>
+
                            </p>
 +
                            <p>
 +
                                We cannot draw any thorough conclusions. Due to time constraints we were unfortunately unable to repeat the experiment. However, it seems likely that presence of IgG is linked to an increase in fluorescent signaling, but as we also see this signal increase in the non-spheroplasted cells it is also possible that we observe a non-specific activation of Cpx. Further research is definitely needed before conclusions can be drawn from this experiment.
  
                          
+
                         </section>
                      
+
                     </section>
  
                <!-- References -->
+
                    <!-- References -->
                <section class="references">
+
                    <section class="references">
                    <div class="Textbox Citations">
+
                        <div class="Textbox Citations">
                        <h3>
+
                            <h3>
 
References
 
References
 
</h3>
 
</h3>
  
                        <ol>
+
                            <ol>
                            <li>Zohar-Perez, C., Chernin, L., Chet, I., & Nussinovitch, A. (2003). Structure of Dried Cellular Alginate Matrix Containing Fillers Provides Extra Protection for Microorganisms against UVC Radiation Structure of Dried Cellular Alginate Matrix Containing Fillers Provides Extra Protection for Microorganisms against UVC Radiation. <i>Radiation Research Society</i>, 160(2), 198–204.</li>
+
                                <li>Zohar-Perez, C., Chernin, L., Chet, I., & Nussinovitch, A. (2003). Structure of Dried Cellular Alginate Matrix Containing Fillers Provides Extra Protection for Microorganisms against UVC Radiation. <i>Radiation Research Society</i>, 160(2), 198–204.</li>
<li>T. Kerppola, “Bimolecular fluorescence complementation (BiFC) analysis as a probe of protein interactions in living cells,” <i>Annu. Rev. Biophys.</i>, vol. 37, pp. 465–87, 2008.</li>
+
                                <li>T. Kerppola, “Bimolecular fluorescence complementation (BiFC) analysis as a probe of protein interactions in living cells,” <i>Annu. Rev. Biophys.</i>, vol. 37, pp. 465–87, 2008.</li>
<li>Nagai, T., Ibata, K., Park, E. S., Kubota, M., & Mikoshiba, K. (2001). A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. <i>Nature Biotechnology</i>, 20, 1585–1588.</li>
+
                                <li>Nagai, T., Ibata, K., Park, E. S., Kubota, M., & Mikoshiba, K. (2001). A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. <i>Nature Biotechnology</i>, 20, 1585–1588.</li>
</ol>
+
                                <li>Nilsson, Björn, et al. "A synthetic IgG-binding domain based on staphylococcal protein A." <i>Protein Engineering, Design and Selection</i> 1.2 (1987): 107-113.</li>
 +
                                <li>Raivio, Tracy L., et al. "Tethering of CpxP to the inner membrane prevents spheroplast induction of the Cpx envelope stress response." <i>Molecular microbiology</i> 37.5 (2000): 1186-1197.</li>
 +
<li>Muller, S., Zhao, Y., Brown, T. L., & Morgan, A. C. (2005). TransMabs: cell-penetrating antibodies , the next generation. <i>Expert Opinion on Biological Therapy</i>, 5(2), 237–241.</li>                               
 +
<li>Fikes, John D., and P. J. Bassford. "Export of unprocessed precursor maltose-binding protein to the periplasm of Escherichia coli cells." <i>Journal of bacteriology</i> 169.6 (1987): 2352-2359.</li>
 +
                               
 +
                                <li>Ranjit, D. K., & Young, K. D. (2013). The Rcs Stress Response and Accessory Envelope Proteins Are Required for De Novo Generation of Cell Shape in Escherichia coli. <i>Journal of Bacteriology</i>, 195(11), 2452–2462.</li>
 +
                            </ol>
  
                    </div>
+
                        </div>
  
                </section>
+
                    </section>
  
 +
                </div>
 
             </div>
 
             </div>
 
         </div>
 
         </div>
 +
 
     </div>
 
     </div>
  
 
</div>
 
</div>
  
</div>
 
</div>
 
 
<div class="col-md-2 hidden-xs Main-Right-Column">
 
<div class="col-md-2 hidden-xs Main-Right-Column">
  
 
</div>
 
</div>
  
</div>
+
 
</div>
+
  
 
</html>
 
</html>
 
{{Wageningen_UR/PageEnd}} {{Wageningen_UR/MainJSv2}}
 
{{Wageningen_UR/PageEnd}} {{Wageningen_UR/MainJSv2}}
 
</div>
 
 
 
<div class="column half_size">
 
 
<h4> What should we do for our demonstration?</h4>
 
 
<h5> Standard teams </h5>
 
 
<p>
 
If you have built a proof of concept system, you can demonstrate it working under real world conditions. If you have built a biological device that is intended to be a sensor, can you show it detecting whatever it is intended to sense. If it is intended to work in the field, you can show how this might work using a simulated version in the lab, or a simulation of your device in the field.<strong> Please note biological materials must not be taken out of the lab</strong>.
 
</p>
 
</div>
 
 
<div class="column half_size">
 
 
<br>
 
<h5> Special track teams </h5>
 
 
<p>
 
Special track teams can achieve this medal criterion by bringing their work to the Jamboree and showcasing it in the track event. Art & Design, Measurement, Hardware and Software tracks will all have showcase events at the Giant Jamboree.<strong> Please note biological materials must not be taken out of the lab</strong>.
 
</p>
 
 
 
</div>
 
 
 
 
</html>
 

Latest revision as of 04:37, 19 November 2017

Demonstrate

Here we show how we brought individual lab projects together and how we implemented them in our device! We performed experiments in which we show that our cells are still viable after drying (which means that they can be safely shipped and still work properly), and that we can measure fluorescence in blood serum.

We combined the "Specific Visualization" and "Fluorescent Protein" modules, by which we aimed to optimize the fluorescent signaling system of Mantis. Furthermore we combined the "Signal Transduction" and "Specific Visualization" modules to directly measure antigens by coupling the affinity molecule, Cpx signal transduction and Bimolecular Fluorescence Complementation (BiFC) specific visualization.



Cell Drying

In order to ship our bacterial system to the local healthcare center (and to be used in the field later) we need to dry the cells in order to be able to ship them safely and keep them viable.

The first experiment consisted of making an overnight culture of Escherichia coli DH5α. Different amounts of kaolin clay (Merck) [1] were added to 2 mL of this culture (in duplo) and left to dry overnight in a laminar flow cabinet on a Petri dish. The next day the cell/clay mixture was scraped off the Petri dish and resuspended in 1 ml of SOC medium. Of this suspension, 100 µl was put on LB agar plates and left to incubate overnight at 37ºC. The next day, the number of colonies were counted and compared to the control, to which no kaolin clay was added. This experiment was repeated under identical conditions, but the drying period was extended to two weeks.

In Figure 1, the number of colonies normalized with regards to the control sample is given on the Y-axis. A clear difference in the survival rate of the bacteria that were revived after 1 day when compared to the rest can be observed. The sample to which 0.1 grams of clay was added to the cell culture has a significantly higher survival rate compared to the control sample. This result gives an indication that drying cells in a kaolin clay matrix is an improvement over drying cells without a clay matrix.

However, when samples were kept dry for 2 weeks at room temperature there seems to be no significant difference in the survival rate compared to the control sample.

Figure 1: Relative survival rates of E. coli dried in a clay matrix as opposed drying without cell matrix.


Cell Viability and Fluorescence in Blood Serum

Next up, we need to know if our cells can survive and function properly when we add a blood sample to measure antigens. We took several steps to investigate this. First, we analyzed if E. coli could grow in (dilutions of) horse blood serum. To do this, we grew cultures with several ratios of Lysogeny Broth (LB) to horse blood serum overnight. The results can be found in Figure 2.

Figure 2: E. coli is grown in LB with added horse blood serum in different ratios. Cells were grown overnight in 2 mL cultures and the optical density at 600 nm was measured after 18 hours. Culture growth relative to the 0% blood serum sample (%) is plotted.

We show that E. coli is able to grow in horse blood serum concentrations up to 75%. This means that our cells would be viable when a small amount of growth medium is added before measuring, which prevents a high dilution of the antigen and, subsequently, a lower fluorescent signal.

In addition, we tested if fluorescence can be measured in blood. We grew E. coli K12 containing eYFP under control of the araC/pBAD promoter overnight in LB. These cells were centrifuged and resuspended in 1 mL of LB with added horse blood serum (the same dilutions were used as in the viability test above) and YFP was matured at 30 °C. Fluorescence was measured after six hours.

Figure 3: eYFP fluorescence measured in E. coli resuspended in several LB to horse blood serum ratios. eYFP was excited at 512 nm and measured at 528 nm. Measurements taken after 6 hours.

Here we show that fluorescence can be measured in all blood serum dilutions, whereas the negative controls containing no eYFP show negligible fluorescence.



Improving the Fluorescent Signal

We visualize antigen binding using the Cpx pathway by fusing split fluorophores to interacting proteins. Through a combination of wet- and dry-lab work, we found that a system based on CpxR dimerization yields the best results using Bimolecular Fluorescence Complementation (BiFC) (Figure 4). We used eYFP, split after amino acid 154, as the reporter. This is a commonly used fluorescent reporter in BiFC [2].

We aim to improve this reporter, both in signal intensity and response time. During our "Fluorescent Protein" project we tested a number of fluorescent proteins, of which mVenus showed the shortest maturation time. Furthermore mVenus is designed to have a fast and efficient maturation time [3], exactly what we need!

Also, our Cpx pathway model showed that several interactions of the Cpx pathway visualization can be improved, of which using a fluorescent protein with a decreased maturation time was the most feasible to attempt in a laboratory setting.

We fused mVenus-termini to the C-terminus of CpxR in the same fashion as we did with eYFP and transformed this to E. coli K12. Experiments with mVenus were performed using the same protocol with optimal induction and activation parameters used during experiments with eYFP, and can be found here.

Figure 5: CpxR dimerization visualized using eYFP (left) and mVenus (right), with a L-arabinose concentration of 0.2% (w/v) and different activator (KCl) concentrations over time.

The results show that usage of mVenus over eYFP as a reporter protein increases the produced fluorescent signal more then five times. Unfortunately, the background signal also increases a lot, which means we lose specificity of our response. We hypothesize that the maturation rate of mVenus is too high, which means that many non-specific interactions become irreversible, leading to high fluorescent signals even when no activator is present. This means that mVenus is not a suitable candidate to visualize antigen binding within our diagnostic.

During this project, more reporter proteins were tested. Unfortunately we didn’t have time to test these in the CpxR dimerization setup. At this moment, we recommend testing sfGFP as a reporter for antigen binding. We found that sfGFP is thermostable, i.e. it matures efficiently at high temperatures, while still being one of the fastest and brightest reporters we tested. You can see the results of these experiments here.



Directly Visualizing Antigen Binding

Here we test the direct coupling of the projects “Signal Transduction” and “Specific Visualization”, where we express the whole detection system in one cell, from affinity body to BiFC (Figure 6). While we induced Cpx activation by addition of KCl in the Specific Visualization project (to mimic antigen presence), here we actually measure antigen binding.

A functional affinity body against rabbit IgG [4] was fused to the N-terminus of Cpx inhibitor CpxP (which resides in the periplasm [5]). To determine if IgG can induce the Cpx pathway (BBa_K2387025), the outer membrane of E. coli has to be removed, as IgG cannot penetrate the outer membrane [6]. This is done through a method called spheroplasting. To prevent CpxP from freely titrating away from the membrane it is tethered to the inner membrane by fusion to a transmembrane Maltose-Binding Protein (MBP) mutant [7]. This fusion was placed under control of the IPTG inducible tac promoter (BBa_K864400).

To rapidly translate the generated signal upon IgG binding, Cpx pathway activation is visualized using BiFC. Split eYFP is used as a reporter, and its N- and C-termini are fused to the C-terminus of response regulator CpxR (BBa_K2387032). These fusions were placed under control of the L-arabinose inducible pBad/araC promoter(BBa_BI0500) . Upon dimerization of CpxR, as a result of the Cpx system activation, the two eYPF halves are combined, leading to yellow fluorescence.

To combine these systems (Figure 6), E. coli K12ΔCpxP was cotransformed with these systems. BBa_K2387025 was placed in medium copy number plasmid pSB3T5 to enable this.

Cells were grown following the spheroplasting protocol. Cells were induced with 0.2% L-arabinose and 0.05 - 0.2 mM IPTG before growing them at 37 °C; the Cpx system was activated by addition of 0.1 mg IgG at timepoint 0 min. As a control, non-spheroplasted cells were used; we assume IgG cannot penetrate the outer membrane [6]. Fluorescence was measured at 27 °C. spheroplasts are expected to remain for five generation before fully regenerating their outer membrane [8].

Figure 7: Fluorescence/OD600 values measured over time. Native E. coli K12ΔCpxP (JW5558(-)) were used as negative controls for both spheroplasted (Sp.) and non-spheroplasted (non-Sp.) cultures. E. coli K12ΔCpxP containing CpxP-Affibody-MBP fusion (BBa_K2387025) and CpxR-eYFPn-CpxR-eYFPc fusions (BBa_K2387032)(CpxR-Ab) were induced with 0.2% L-arabinose (L-ara) and 0.05 - 0.2 mM IPTG. 0.1 mg IgG was added at time-point 0. Spheroplasted and non-spheroplasted cells were induced and activated equally.

In Figure 7 it is visible that a fluorescent signal is generated after addition of IgG. In both the spheroplasted and non-spheroplasted cells an increase in fluorescence is visible within the first 100 minutes, after which the signal decreases and stabilizes. For both the spheroplasted and non-spheroplasted cells the measured fluorescent signals are much higher than in their negative controls.

We cannot draw any thorough conclusions. Due to time constraints we were unfortunately unable to repeat the experiment. However, it seems likely that presence of IgG is linked to an increase in fluorescent signaling, but as we also see this signal increase in the non-spheroplasted cells it is also possible that we observe a non-specific activation of Cpx. Further research is definitely needed before conclusions can be drawn from this experiment.

References

  1. Zohar-Perez, C., Chernin, L., Chet, I., & Nussinovitch, A. (2003). Structure of Dried Cellular Alginate Matrix Containing Fillers Provides Extra Protection for Microorganisms against UVC Radiation. Radiation Research Society, 160(2), 198–204.
  2. T. Kerppola, “Bimolecular fluorescence complementation (BiFC) analysis as a probe of protein interactions in living cells,” Annu. Rev. Biophys., vol. 37, pp. 465–87, 2008.
  3. Nagai, T., Ibata, K., Park, E. S., Kubota, M., & Mikoshiba, K. (2001). A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nature Biotechnology, 20, 1585–1588.
  4. Nilsson, Björn, et al. "A synthetic IgG-binding domain based on staphylococcal protein A." Protein Engineering, Design and Selection 1.2 (1987): 107-113.
  5. Raivio, Tracy L., et al. "Tethering of CpxP to the inner membrane prevents spheroplast induction of the Cpx envelope stress response." Molecular microbiology 37.5 (2000): 1186-1197.
  6. Muller, S., Zhao, Y., Brown, T. L., & Morgan, A. C. (2005). TransMabs: cell-penetrating antibodies , the next generation. Expert Opinion on Biological Therapy, 5(2), 237–241.
  7. Fikes, John D., and P. J. Bassford. "Export of unprocessed precursor maltose-binding protein to the periplasm of Escherichia coli cells." Journal of bacteriology 169.6 (1987): 2352-2359.
  8. Ranjit, D. K., & Young, K. D. (2013). The Rcs Stress Response and Accessory Envelope Proteins Are Required for De Novo Generation of Cell Shape in Escherichia coli. Journal of Bacteriology, 195(11), 2452–2462.